Co-Host: Jay Raman, MD, FACS
At the conclusion of these activities, participants will be able to:
1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC.
2. Facilitate discussions with patients and caregivers regarding RCC treatment options.
CME Available: auau.auanet.org/node/26091
This educational series is supported by independent educational grants from:
Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Genomic Health
Merck
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma
